CY2407B1 - Acellular pertussis vaccine with diphthriae- and tetanus-toxoids. - Google Patents

Acellular pertussis vaccine with diphthriae- and tetanus-toxoids.

Info

Publication number
CY2407B1
CY2407B1 CY0400014A CY0400014A CY2407B1 CY 2407 B1 CY2407 B1 CY 2407B1 CY 0400014 A CY0400014 A CY 0400014A CY 0400014 A CY0400014 A CY 0400014A CY 2407 B1 CY2407 B1 CY 2407B1
Authority
CY
Cyprus
Prior art keywords
diphthriae
toxoids
tetanus
pertussis vaccine
acellular pertussis
Prior art date
Application number
CY0400014A
Other languages
English (en)
Inventor
Patrick Florent
Jean Stephenne
Christian Vandecasserie
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of CY2407B1 publication Critical patent/CY2407B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CY0400014A 1996-11-07 2004-02-26 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids. CY2407B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition

Publications (1)

Publication Number Publication Date
CY2407B1 true CY2407B1 (en) 2004-09-10

Family

ID=10802615

Family Applications (2)

Application Number Title Priority Date Filing Date
CY0400014A CY2407B1 (en) 1996-11-07 2004-02-26 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids.
CY0600031A CY2568B1 (en) 1996-11-07 2006-11-09 Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY0600031A CY2568B1 (en) 1996-11-07 2006-11-09 Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids

Country Status (30)

Country Link
EP (2) EP0941117B1 (da)
JP (1) JP3980652B2 (da)
KR (1) KR100518044B1 (da)
CN (1) CN1130226C (da)
AR (1) AR011509A1 (da)
AT (2) ATE222773T1 (da)
AU (1) AU710475B2 (da)
BR (2) BRPI9712917B8 (da)
CA (1) CA2271008C (da)
CO (1) CO4910171A1 (da)
CY (2) CY2407B1 (da)
CZ (1) CZ295954B6 (da)
DE (3) DE69715031T2 (da)
DK (2) DK1240905T5 (da)
ES (2) ES2182131T3 (da)
GB (1) GB9623233D0 (da)
HK (2) HK1050473B (da)
HU (1) HU224126B1 (da)
IL (1) IL129530A (da)
LU (1) LU91183I2 (da)
NO (2) NO320186B1 (da)
NZ (1) NZ335384A (da)
PL (1) PL188460B1 (da)
PT (2) PT1240905E (da)
SA (1) SA98181128B1 (da)
SI (2) SI1240905T1 (da)
TR (1) TR199900979T2 (da)
TW (1) TW471971B (da)
WO (1) WO1998019702A1 (da)
ZA (1) ZA979984B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (fr) * 1998-11-26 2000-05-31 Pasteur Merieux MSD Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
CN102844047B (zh) 2009-09-02 2017-04-05 诺华股份有限公司 含tlr活性调节剂的免疫原性组合物
ES2458355T3 (es) 2010-09-01 2014-05-05 Novartis Ag Adsorción de inmunopotenciadores sobre sales metálicas insolubles
US20140112950A1 (en) 2011-03-02 2014-04-24 Manmohan Singh Combination vaccines with lower doses of antigen and/or adjuvant
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
AU2013229432A1 (en) * 2012-03-08 2014-10-16 Novartis Ag Adjuvanted formulations of booster vaccines
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
AU2013301312A1 (en) 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
US8916173B2 (en) 2013-03-08 2014-12-23 Crucell Holland B.V. Acellular pertussis vaccine
KR20160040290A (ko) 2013-08-05 2016-04-12 글락소스미스클라인 바이오로지칼즈 에스.에이. 조합 면역원성 조성물
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
ZA88488B (en) 1987-01-30 1988-10-26 Smith Kline Rit Hepatitis b virus surface antigens and hybrid antigens containing them
EP0304578B1 (en) 1987-06-22 2001-10-24 Medeva Holdings Bv Peptide comprising hepatitis B surface antigen
ATE105858T1 (de) 1987-07-17 1994-06-15 Rhein Biotech Ges Fuer Biotech Dna-moleküle, die für fmdh-kontrollabschnitte und strukturgene für ein protein mit fmdh-aktivität kodieren, sowie deren anwendung.
DE69031556T2 (de) 1989-07-25 1998-05-14 Smithkline Beecham Biologicals S.A., Rixensart Antigene sowie Verfahren zu deren Herstellung
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
PT835663E (pt) * 1992-05-23 2010-01-04 Glaxosmithkline Biolog Sa Vacinas combinadas compreendendo o antigénio de superfície da hepatite b e outros antigénios

Also Published As

Publication number Publication date
BRPI9712917B1 (pt) 2019-12-03
BR9712917A (pt) 1999-12-07
HK1050473B (zh) 2006-03-03
IL129530A (en) 2005-11-20
HU224126B1 (hu) 2005-05-30
ES2240647T3 (es) 2005-10-16
CY2568B1 (en) 2008-07-02
CN1236321A (zh) 1999-11-24
PL333127A1 (en) 1999-11-22
DK0941117T3 (da) 2002-11-18
GB9623233D0 (en) 1997-01-08
ES2182131T3 (es) 2003-03-01
NZ335384A (en) 2000-10-27
HK1022638A1 (en) 2000-08-18
ZA979984B (en) 1998-07-23
EP0941117A1 (en) 1999-09-15
IL129530A0 (en) 2000-02-29
TW471971B (en) 2002-01-11
NO992156D0 (no) 1999-05-04
TR199900979T2 (xx) 1999-07-21
EP1240905A1 (en) 2002-09-18
WO1998019702A1 (en) 1998-05-14
DK1240905T3 (da) 2005-07-18
PT941117E (pt) 2002-12-31
DK1240905T5 (da) 2010-01-11
CO4910171A1 (es) 2000-04-24
CZ164099A3 (cs) 1999-10-13
ATE222773T1 (de) 2002-09-15
LU91183I2 (fr) 2005-09-20
AR011509A1 (es) 2000-08-30
CZ295954B6 (cs) 2005-12-14
AU5319698A (en) 1998-05-29
DE69733285D1 (de) 2005-06-16
SI1240905T1 (en) 2005-10-31
NO992156L (no) 1999-05-04
DE69733285T2 (de) 2006-01-12
PL188460B1 (pl) 2005-02-28
EP0941117B1 (en) 2002-08-28
DE122005000046I1 (de) 2005-12-29
BRPI9712917B8 (pt) 2021-05-25
ATE295178T1 (de) 2005-05-15
EP1240905B3 (en) 2009-08-26
CN1130226C (zh) 2003-12-10
ES2240647T7 (es) 2010-03-31
PT1240905E (pt) 2005-09-30
NO2006005I2 (no) 2010-04-12
JP3980652B2 (ja) 2007-09-26
HK1050473A1 (en) 2003-06-27
KR20000053092A (ko) 2000-08-25
NO320186B1 (no) 2005-11-07
EP1240905B1 (en) 2005-05-11
NO2006005I1 (no) 2006-05-08
KR100518044B1 (ko) 2005-09-30
JP2001503422A (ja) 2001-03-13
DE69715031T2 (de) 2003-05-08
DE69715031D1 (de) 2002-10-02
HUP9904287A1 (hu) 2000-04-28
HUP9904287A3 (en) 2001-05-28
SA98181128B1 (ar) 2006-03-25
AU710475B2 (en) 1999-09-23
CA2271008A1 (en) 1998-05-14
CA2271008C (en) 2008-07-22
SI0941117T1 (en) 2002-12-31
DE69733285T3 (de) 2010-03-25

Similar Documents

Publication Publication Date Title
CY2568B1 (en) Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids
HUP9904549A3 (en) Vaccines
ZA9811848B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
HK1002055A1 (en) Polyepitope vaccines.
EP0958373A4 (en) Vaccines.
ZA976815B (en) Vaccine composition.
ZA975034B (en) Airship.
GB9410922D0 (en) Vaccines
GB9626864D0 (en) Vaccine
GB9625968D0 (en) Vaccine
EP0681480A4 (en) RECOGNIN VACCINES.
GB9609252D0 (en) Vaccines
AU715243C (en) Acellular antibordetella vaccine
ZA952806B (en) Vaccines
GB9614182D0 (en) Vaccines
GB9604595D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9602617D0 (en) Vaccines
ZA987303B (en) Vaccine.
ZA967198B (en) Vaccines.